Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2)-A Randomized Controlled Trial.

Anna Obermayer,Norbert J Tripolt,Peter N Pferschy,Harald Kojzar,Faisal Aziz,Alexander Müller,Markus Schauer,Abderrahim Oulhaj,Felix Aberer,Caren Sourij,Hansjörg Habisch,Tobias Madl,Thomas Pieber,Barbara Obermayer-Pietsch,Vanessa Stadlbauer,Harald Sourij

Diabetes care（2023）

引用 7|浏览44

暂无评分

摘要

IF is a safe and feasible dietary option to ameliorate glycemic control while reducing total daily insulin dose and body weight in insulin-treated people with type 2 diabetes.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要